Speaker(s):
Scott Opalka, PharmD, MTM Pharmacist, Geisinger - has nothing to disclose.
Julia Iskra, PharmD, Clinical Pharmacist in Fellowship, Geisinger - has nothing to disclose
Moderator(s):
Leonie Vachon, NP, Western Region GI APP Chief, Geisinger - has nothing to disclose.
Learning Objectives:
At the conclusion of this session, the participant should be able to:
Identify Updates to the Gastroenterology Clinical Pharmacy Service
Apply differences between biologics to develop a patient tailored care plan
Evaluate where medical cannabis can fit into a patient’s care plan & other consideration
Disclosure of Relevant Financial Relationships with/without Commercial Interests:
The Planning Committee consisting of Karla Leschinsky, PA-C, Leonie Vachon, CRNP, Hannah Clark, RN, Alyssa Jones, PharmD, and Lorella Thomas, CRNP have no identified disclosures.
CE Committee Member/Content Reviewers have nothing to disclose.
Any/All relevant financial relationships have been mitigated.
Content Disclosure:
This presentation/content is HIPAA compliant.
Commercial Support for this Session
None
- 1.00 AAPA Category I CME
- 1.00 ACPE
- 1.00 ANCC
- 1.00 Participation Credit

Facebook
X
LinkedIn
Forward